Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
So-Young InternationalSY +3.65%71 3-Year EBITDA Growth Rate is -58.40% as of Mar. 2026. GuruFocus rates SY with a GF Score™ of 71/100 and a GF Value™ of $1.54 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 523 Healthcare Providers & Services companies, So-Young International ranks worse than 98.28% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was -58.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of So-Young International was 29.50% per year. The lowest was -58.40% per year. And the median was -25.90% per year.
So-Young International (NAS:SY) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
So-Young International 3-Year EBITDA Growth Rate Related Terms
SY vs AMWL, LFMD, SPOK: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, So-Young International's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
So-Young International 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, So-Young International's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where So-Young International's 3-Year EBITDA Growth Rate falls into.
So-Young International 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -58.40% mean?
So-Young International (SY) has a 3-Year EBITDA Growth Rate of -58.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for So-Young International and its competitors. According to the industry distribution chart, So-Young International ranks #514 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 98.3%.
Is So-Young International's 3-Year EBITDA Growth Rate too high?
So-Young International's current 3-Year EBITDA Growth Rate is -58.40%. Based on the distribution chart, So-Young International ranks #514 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, So-Young International has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does So-Young International's 3-Year EBITDA Growth Rate compare to AMWL and LFMD?
According to the Healthcare Providers & Services industry distribution chart, So-Young International ranks #514 out of 523 companies for 3-Year EBITDA Growth Rate. This places So-Young International in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for So-Young International and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. So-Young International's current 3-Year EBITDA Growth Rate is -58.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is So-Young International stock overvalued right now?
Based on GuruFocus' analysis, So-Young International (SY) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.54, compared to a current price of $1.99 — trading 29.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -58.40%. So-Young International's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For So-Young International (SY), the current 3-Year EBITDA Growth Rate is -58.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is So-Young International (SY) Overvalued in 2026?
Based on GuruFocus' analysis, So-Young International stock appears to be overvalued.
The current stock price of $1.99 is trading 29.2% above its estimated GF Value™ of $1.54.
GuruFocus considers So-Young International to be Modestly Overvalued.
Key valuation signals for SY:
3-Year EBITDA Growth Rate: -58.40%
GF Value™: $1.54 vs. price of $1.99 (29.2% above fair value)
No single metric tells the full story. See the SY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.
71GF Score
Get the complete analysis for SY
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SY has been successfully added to your 
